Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3,004 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Effect of atorvastatin on in vitro expression of resistin in adipocytes and monocytes/macrophages and effect of atorvastatin treatment on serum resistin levels in patients with type 2 diabetes.
Ichida Y, Hasegawa G, Fukui M, Obayashi H, Ohta M, Fujinami A, Ohta K, Nakano K, Yoshikawa T, Nakamura N. Ichida Y, et al. Among authors: nakano k. Pharmacology. 2006;76(1):34-9. doi: 10.1159/000088948. Epub 2005 Oct 14. Pharmacology. 2006. PMID: 16227702 Clinical Trial.
Increased concentration of pentosidine, an advanced glycation end product, and interleukin-6 in the vitreous of patients with proliferative diabetic retinopathy.
Nakamura N, Hasegawa G, Obayashi H, Yamazaki M, Ogata M, Nakano K, Yoshikawa T, Watanabe A, Kinoshita S, Fujinami A, Ohta M, Imamura Y, Ikeda T. Nakamura N, et al. Among authors: nakano k. Diabetes Res Clin Pract. 2003 Aug;61(2):93-101. doi: 10.1016/s0168-8227(03)00109-8. Diabetes Res Clin Pract. 2003. PMID: 12951277
The alpha-glucosidase inhibitor acarbose reduces the net electronegative charge of low-density lipoprotein in patients with newly diagnosed type 2 diabetes.
Hasegawa G, Kajiyama S, Tanaka T, Imai S, Kozai H, Fujinami A, Ohta M, Obayashi H, Park H, Nakano K, Tanaka M, Shiraishi E, Fukui M, Yoshikawa T, Nakamura N. Hasegawa G, et al. Among authors: nakano k. Clin Chim Acta. 2008 Apr;390(1-2):110-4. doi: 10.1016/j.cca.2008.01.005. Epub 2008 Jan 12. Clin Chim Acta. 2008. PMID: 18230353 Clinical Trial.
Effect of pioglitazone on various parameters of insulin resistance including lipoprotein subclass according to particle size by a gel-permeation high-performance liquid chromatography in newly diagnosed patients with type 2 diabetes.
Nakano K, Hasegawa G, Fukui M, Yamasaki M, Ishihara K, Takashima T, Kitagawa Y, Fujinami A, Ohta M, Hara H, Adachi T, Ogata M, Obayashi H, Nakamura N. Nakano K, et al. Endocr J. 2010;57(5):423-30. doi: 10.1507/endocrj.k10e-006. Epub 2010 Feb 17. Endocr J. 2010. PMID: 20160397 Free article. Clinical Trial.
3,004 results